In conclusion, these results indicate that PLCD3 is upregulated in ESCC, high expression of PLCD3 is closely related to the malignant biological behavior of ESCC, and PLCD3 may play an oncogenic role in ESCC via the PI3K / AKT / P21 pathway. This evidence concerns the gene PLCD3 and esophageal squamous cell carcinoma.